News | Cardiovascular Clinical Studies | June 28, 2016

Two U.K. Studies Validate Weekend Effect Among Heart Patients

Data suggests weekend discharge and admission from hospital affects people with certain heart conditions

U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure

June 28, 2016 — New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial fibrillation or heart failure over the weekend face a higher risk of dying over the next five years than those admitted during normal hours. The research, led by Rahul Potluri, M.D., founder of the ACALM study unit at Aston University, was presented at the British Cardiovascular Society (BCS) Conference, June 6-8 in Manchester.

The study of 42,687 patients with AF, one of the most common forms of abnormal heart rhythm, finds that those admitted outside of normal operating hours (9 a.m.-5 p.m., Monday-Friday) have a 10 percent increased risk of dying in the next five years. The research was adjusted to account for external factors that could influence death rates such as age, gender, ethnic group and the most common causes of mortality in the U.K.

Normally, the heart’s natural pacemaker sends out a regular electrical impulse that travels through the heart. But when someone has AF, impulses fire off from different places in the atria, causing chaotic electrical activity, which makes them have an irregular and sometimes fast pulse. AF affects about one million people in the U.K. – or 1.7 percent of the population – but many more are undiagnosed and do not know they have it.

In a separate study, the researchers also looked at 31,760 heart failure patients discharged from hospitals in the north of England on weekends, finding a 32 percent increased chance of dying over the next five years compared to those sent home during regular weekday hours.

Across the U.K. there are more than 500,000 people diagnosed with heart failure.

Heart failure is a disabling condition and severe heart failure can have a worse life expectancy than many cancers. It is most commonly caused following a heart attack when the heart muscle suffers irreparable damage and can no longer pump blood efficiently around the body. In severe cases people with heart failure are left unable to perform regular day-to-day activities like walking upstairs or are left breathless even when resting. Up to a third of patients admitted to the hospital with heart failure will die within twelve months.

Potluri said, “This study shows that the weekend effect is very much a reality for those suffering two of the most prevalent heart conditions in the U.K. These patients are, quite simply, more likely to die if admitted or discharged outside regular hours, and that trend is particularly noticeable at the weekend.

Paul Carter, M.D., presenting author at the BCS Conference, said: “We took steps during this study to ensure that the comparison between the two groups was as fair as possible.

“It is interesting that both being admitted or discharged from hospital on the weekend confers an increased risk, and one which is sustained in the long-term. We cannot comment on the underlying reasons for this from our study but it suggests that the level of support provided at weekends, from all teams involved in healthcare — in the hospital and in the community — should be addressed.”

Potluri added, “What this research shows is that the weekend effect is not a universal phenomenon. Across the two conditions we studied, its impact was varied, suggesting it can’t be tackled effectively by blanket improvements to care.

“Further research is urgently needed to assess what the implications of the weekend effect are for individual conditions, before any costly changes to services are implemented.”

Read the related article about a similar U.S. study, "Day of the Week PCI-Related Hospitalization Occurs Determines Likelihood of Survival."

For more information: www.bcs.com/conference


Related Content

News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
Subscribe Now